1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Cierpicki, T. Otlewski, J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C2 H4 O 44.053 ACETYL GROUP non-polymer C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 302 1179 10.1006/JMBI.2000.4116 11183783 Determination of a High Precision Structure of a Novel Protein, Linum Usitatissimum Trypsin Inhibitor (Luti), Using Computer-Aided Assignment of Noesy Cross-Peaks 2000 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 7651.771 LINUM USITATISSINUM TRYPSIN INHIBITOR 1 nat polymer LUTI no yes (ACE)SRRCPGKNAWPELVGKSGNMAAATVERENRNVHAIVLKEGSAMTKDFRCDRVWVIVNDHGVVTSVPHIT XSRRCPGKNAWPELVGKSGNMAAATVERENRNVHAIVLKEGSAMTKDFRCDRVWVIVNDHGVVTSVPHIT A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n FLAX sample 4006 SEED LINUM USITATISSIMUM repository Initial release Version format compliance Version format compliance 1 0 1999-12-17 1 1 2011-05-07 1 2 2011-07-13 HELIX DETERMINATION METHOD: AUTHOR PROVIDED. SHEET DETERMINATION METHOD: AUTHOR PROVIDED. PDBE Y PDBE 1999-12-08 REL THE STRUCTURE WAS DETERMINED BASING ON 1760 EXPERIMENTAL RESTRAINTS DERIVED FROM TWO DIMENSIONAL 1H NMR EXPERIMENTS. NOESY CROSSPEAKS WERE ASSIGNED AUTOMATICALY USING NOAH/DYANA PROGRAM. STRUCTURE REFINEMENT WAS ACCOMPLISHED IN CNS. LEAST RESTRAINT VIOLATION AND LOWEST ENERGY 40 20 NOESY TOCSY DQF-COSY 1H-15N HSQC 4.3 pH 293 K simulated annealing 10% H2O/90% D2O BRUNGER refinement CNS 0.9 structure solution NMRPIPE structure solution SPARKY structure solution DYANA structure solution CNS 500 Varian UNITYPLUS ACE 0 n 1 ACE 0 A SER 1 n 2 SER 1 A ARG 2 n 3 ARG 2 A ARG 3 n 4 ARG 3 A CYS 4 n 5 CYS 4 A PRO 5 n 6 PRO 5 A GLY 6 n 7 GLY 6 A LYS 7 n 8 LYS 7 A ASN 8 n 9 ASN 8 A ALA 9 n 10 ALA 9 A TRP 10 n 11 TRP 10 A PRO 11 n 12 PRO 11 A GLU 12 n 13 GLU 12 A LEU 13 n 14 LEU 13 A VAL 14 n 15 VAL 14 A GLY 15 n 16 GLY 15 A LYS 16 n 17 LYS 16 A SER 17 n 18 SER 17 A GLY 18 n 19 GLY 18 A ASN 19 n 20 ASN 19 A MET 20 n 21 MET 20 A ALA 21 n 22 ALA 21 A ALA 22 n 23 ALA 22 A ALA 23 n 24 ALA 23 A THR 24 n 25 THR 24 A VAL 25 n 26 VAL 25 A GLU 26 n 27 GLU 26 A ARG 27 n 28 ARG 27 A GLU 28 n 29 GLU 28 A ASN 29 n 30 ASN 29 A ARG 30 n 31 ARG 30 A ASN 31 n 32 ASN 31 A VAL 32 n 33 VAL 32 A HIS 33 n 34 HIS 33 A ALA 34 n 35 ALA 34 A ILE 35 n 36 ILE 35 A VAL 36 n 37 VAL 36 A LEU 37 n 38 LEU 37 A LYS 38 n 39 LYS 38 A GLU 39 n 40 GLU 39 A GLY 40 n 41 GLY 40 A SER 41 n 42 SER 41 A ALA 42 n 43 ALA 42 A MET 43 n 44 MET 43 A THR 44 n 45 THR 44 A LYS 45 n 46 LYS 45 A ASP 46 n 47 ASP 46 A PHE 47 n 48 PHE 47 A ARG 48 n 49 ARG 48 A CYS 49 n 50 CYS 49 A ASP 50 n 51 ASP 50 A ARG 51 n 52 ARG 51 A VAL 52 n 53 VAL 52 A TRP 53 n 54 TRP 53 A VAL 54 n 55 VAL 54 A ILE 55 n 56 ILE 55 A VAL 56 n 57 VAL 56 A ASN 57 n 58 ASN 57 A ASP 58 n 59 ASP 58 A HIS 59 n 60 HIS 59 A GLY 60 n 61 GLY 60 A VAL 61 n 62 VAL 61 A VAL 62 n 63 VAL 62 A THR 63 n 64 THR 63 A SER 64 n 65 SER 64 A VAL 65 n 66 VAL 65 A PRO 66 n 67 PRO 66 A HIS 67 n 68 HIS 67 A ILE 68 n 69 ILE 68 A THR 69 n 70 THR 69 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A A O HG1 MET THR 20 24 1.57 4 A A O HD1 VAL HIS 65 67 1.45 10 A A O HD1 VAL HIS 65 67 1.58 19 A A O HD1 VAL HIS 65 67 1.47 1 A ARG 2 -152.67 70.91 1 A ARG 3 -151.12 88.91 1 A ALA 42 -66.86 81.85 1 A ASP 46 -52.04 171.95 1 A ILE 68 -39.34 106.31 2 A ARG 3 -151.35 89.23 2 A TRP 10 -111.40 74.93 2 A ASP 46 -47.25 161.12 2 A ILE 68 -47.51 109.34 3 A ARG 2 58.87 80.11 3 A ARG 3 -174.42 98.13 3 A TRP 10 -113.39 67.46 3 A PRO 66 -58.86 97.49 4 A ARG 2 -156.96 72.62 4 A ARG 3 -101.52 74.36 4 A PRO 5 -69.56 63.46 4 A LYS 7 -33.23 143.52 4 A TRP 10 -108.79 74.81 4 A SER 41 -68.09 -178.09 4 A ASP 46 -45.95 159.36 5 A ARG 2 -103.22 52.50 5 A ARG 3 -153.68 84.24 5 A TRP 10 -109.52 74.36 5 A ARG 30 -63.70 1.88 5 A PRO 66 -60.32 99.84 6 A ARG 2 -154.94 73.77 6 A PRO 5 -63.23 -176.83 6 A TRP 10 -116.71 67.35 6 A ASN 29 -119.44 78.18 6 A ALA 42 -62.54 81.14 6 A ASP 46 -37.74 152.65 6 A PRO 66 -56.92 98.32 7 A TRP 10 -113.52 74.88 7 A SER 41 -65.73 -173.93 7 A ASP 46 -45.52 155.00 7 A ILE 68 -44.11 103.54 8 A ARG 2 -158.38 75.30 8 A ARG 3 -174.40 94.83 8 A TRP 10 -119.49 74.16 8 A ARG 30 -64.62 1.88 8 A SER 41 -66.01 -174.24 8 A PRO 66 -58.06 103.39 8 A ILE 68 -41.81 107.40 9 A ARG 2 -154.69 61.84 9 A SER 41 -72.76 -164.23 10 A ARG 2 -159.47 77.87 10 A ARG 3 46.82 83.28 10 A TRP 10 -108.65 74.14 10 A SER 41 -68.69 -166.09 10 A ILE 68 -38.28 116.43 11 A ARG 2 -113.85 59.28 11 A ARG 3 53.73 81.31 11 A ASN 29 -118.73 79.48 11 A SER 41 -70.46 -162.38 11 A ILE 68 -36.63 116.52 12 A ARG 2 -155.58 64.14 12 A PRO 5 -66.81 62.57 12 A TRP 10 -108.00 73.95 12 A PRO 66 -59.42 99.04 13 A ARG 2 51.21 78.50 13 A ARG 3 -164.79 105.24 13 A TRP 10 -110.86 73.11 13 A SER 41 -66.44 -167.72 13 A ASP 46 -46.48 159.56 13 A PRO 66 -54.47 95.46 13 A ILE 68 -44.23 109.39 14 A ARG 2 -168.20 68.16 14 A TRP 10 -114.82 70.06 14 A SER 41 -61.43 -178.00 14 A PRO 66 -59.05 100.30 14 A ILE 68 -47.71 109.92 15 A ARG 2 -106.69 60.86 15 A ARG 3 53.28 97.57 15 A TRP 10 -119.45 72.13 15 A SER 41 -67.61 -167.68 16 A ARG 3 -161.54 98.99 16 A TRP 10 -115.48 72.85 16 A GLU 39 -56.64 107.92 16 A ASP 46 -41.88 163.34 16 A PRO 66 -60.81 90.82 17 A ARG 2 51.64 81.90 17 A ARG 3 -167.19 94.17 17 A TRP 10 -112.62 69.89 17 A SER 41 -68.27 -166.58 18 A ARG 2 57.97 78.16 18 A ARG 3 -160.99 67.63 18 A TRP 10 -110.34 68.93 18 A ARG 30 -62.58 0.97 18 A SER 41 -67.62 -176.01 18 A PRO 66 -65.69 89.29 19 A ARG 2 -160.46 84.66 19 A ARG 3 -154.01 77.34 19 A TRP 10 -112.52 73.48 19 A SER 41 -67.62 -179.32 19 A ASP 46 -44.81 160.84 19 A PRO 66 -57.75 92.17 20 A ARG 3 55.77 90.65 20 A TRP 10 -119.73 68.15 20 A SER 41 -69.71 -177.22 20 A PRO 66 -57.91 99.86 LINUM USITATISSINUM TRYPSIN INHIBITOR Solution structure of Linum usitatissinum trypsin inhibitor (LUTI) 1 N N A TRP 10 A TRP 11 HELX_P A LEU 13 A LEU 14 5 H1 4 A GLY 18 A GLY 19 HELX_P A GLU 28 A GLU 29 1 H2 11 disulf 2.031 A CYS 4 A SG CYS 5 1_555 A CYS 49 A SG CYS 50 1_555 covale 1.332 A ACE 0 A C ACE 1 1_555 A SER 1 A N SER 2 1_555 SERINE PROTEINASE INHIBITOR SERINE PROTEINASE INHIBITOR, TRYPSIN INHIBITOR 1DWM PDB 1 1DWM 0 69 1DWM 0 69 1DWM A 1 1 70 1 1 A HIS 33 A HIS 34 A LYS 38 A LYS 39 A ARG 51 A ARG 52 A VAL 56 A VAL 57 1 P 1